mRNA expression
Gene:
TSGA10 (official gene symbol)Other symbol:
TSGA10CT family:
CT79CT identifier:
CT79Aliases from NCBI:
CEP4LGene expression pattern ? : Testis-selective
High-throughput data (expression in cancer samples)
SAGE(short, 10 nt tags) Show
SAGE(long, 17 nt tags) Show
MPSS (short, 13 nt tags) Show
EST Show
Published data of mRNA expression in normal tissues
Show| Tissue | Methodology | PMID |
|---|---|---|
| Testis | Northern blot | 11179690 |
| Fetal stomach | RT-PCR | 14585816 |
| Fetal kidney | RT-PCR | 14585816 |
| Testis | qRT-PCR | 15107545 |
| Pancreas | qRT-PCR | 15107545 |
| Fetal sternum | RT-PCR | 14585816 |
| Fetal limb | RT-PCR | 14585816 |
| Peripheral blood mononuclear | RT-PCR | 16120156 |
| Skin (foreskin) | RT-PCR | 16120156 |
| Fibroblasts | RT-PCR | 16120156 |
Published data of mRNA expression in neoplasias
Hematologic malignacies Show
| Tumor Subtype | Sample type | Frequency | Methodology | PMID |
|---|---|---|---|---|
| Acute lymphoblastic leukemia |
Bone marrow | 44/52 (85%) | RT-PCR | 16406020 |
| Acute lymphoblastic leukemia |
Peripheral blood | 14 /14 (100%) | RT-PCR | |
| Lymphoma |
4 ⁄4 (100%) | RT-PCR | 16120156 | |
| Mycosis fungoides |
10 ⁄10 (100%) | RT-PCR | ||
| S�zary syndrome |
6 ⁄6 (100%) | RT-PCR |
Bladder cancer Show
| Tumor Subtype | Sample type | Frequency | Methodology | PMID |
|---|---|---|---|---|
| Bladder carcinoma |
8/21 (38%) | qRT-PCR | 15107545 |
Brain cancer Show
| Tumor Subtype | Sample type | Frequency | Methodology | PMID |
|---|---|---|---|---|
| Brain tumor |
15/18 (83%) | Nested RT-PCR | 17920210 |
Breast cancer Show
| Tumor Subtype | Sample type | Frequency | Methodology | PMID |
|---|---|---|---|---|
| Breast carcinoma |
10/15 (66%) | Nested RT-PCR | 17920210 | |
| Breast carcinoma |
35/50 (70%) | RT-PCR | 23396665 |
Hepatobiliary cancer Show
| Tumor Subtype | Sample type | Frequency | Methodology | PMID |
|---|---|---|---|---|
| Hepatocellular carcinoma |
4/20 (20%) | qRT-PCR | 15107545 |
Melanocytic lesion Show
| Tumor Subtype | Sample type | Frequency | Methodology | PMID |
|---|---|---|---|---|
| Melanoma |
6/7 (59%) | Nested RT-PCR | 17920210 | |
| Melanoma |
5 ⁄5 (100%) | RT-PCR | 16120156 | |
| Melanoma |
1/21 (5%) | qRT-PCR | 15107545 |
Ovarian cancer Show
| Tumor Subtype | Sample type | Frequency | Methodology | PMID |
|---|---|---|---|---|
| Ovarian carcinoma |
7/20 (35%) | qRT-PCR | 15107545 |
Pancreatic cancer Show
| Tumor Subtype | Sample type | Frequency | Methodology | PMID |
|---|---|---|---|---|
| Pancreatic carcinoma |
3 ⁄3 (100%) | RT-PCR | 16120156 |
Prostate cancer Show
| Tumor Subtype | Sample type | Frequency | Methodology | PMID |
|---|---|---|---|---|
| Prostate carcinoma |
3/20 (15%) | qRT-PCR | 15107545 |
Published data of mRNA expression in Cell Lines
Show| Origin tissue | Cell Line ID | Frequency | Methodology | PMID |
|---|---|---|---|---|
| Breast carcinoma | MCF-7 MDA-23 |
RT-PCR | 23396665 | |
| Keratinocyte (immortalized) | HaCat | RT-PCR | 16120156 | |
| Leukemia | CCRF-CEM Jurkat K-562 Molt4 THP1 |
RT-PCR | 16120156 | |
| Lymphoma (S�zary syndrome) | MyLa | RT-PCR | 16120156 | |
| Melanoma | SK-mel24 SK-mel28 SK-mel29 SK-mel37 |
RT-PCR | 16120156 |
2005-2009© CT Antigens Database